Authors: Patnaik, A Rowinsky, EK Tammara, BK Hidalgo, M Drengler, RL Garner, AM Siu, LL Hammond, LA Felton, SA Mallikaarjun, S Von Hoff, DD Eckhardt, SG

Citation: A. Patnaik et al., Phase I and pharmacokinetic study of the differentiating agent vesnarinonein combination with gemcitabine in patients with advanced cancer, J CL ONCOL, 18(23), 2000, pp. 3974-3985

Authors: Bramer, SL Forbes, WP Mallikaarjun, S

Citation: Sl. Bramer et al., Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease, CLIN PHARMA, 37, 1999, pp. 1-11

Authors: Mallikaarjun, S Forbes, WP Bramer, SL

Citation: S. Mallikaarjun et al., Effect of renal impairment on the pharmacokinetics of cilostazol and its metabolites, CLIN PHARMA, 37, 1999, pp. 33-40

Authors: Bramer, SL Brisson, J Corey, AE Mallikaarjun, S

Citation: Sl. Bramer et al., Effect of multiple cilostazol doses on single dose lovastatin pharmacokinetics in healthy volunteers, CLIN PHARMA, 37, 1999, pp. 69-77

Authors: Mallikaarjun, S Bramer, SL

Citation: S. Mallikaarjun et Sl. Bramer, Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin, CLIN PHARMA, 37, 1999, pp. 79-86

Authors: Mallikaarjun, S Forbes, WP Bramer, SL

Citation: S. Mallikaarjun et al., Interaction potential and tolerability of the coadministration of cilostazol and aspirin, CLIN PHARMA, 37, 1999, pp. 87-93